Top insider buys: Jul 3 – Jul 9, 2023

The largest open-market purchases company insiders reported on SEC Form 4 between Jul 3 – Jul 9, 2023.

Week 27, 2023

#	Company	Who bought	Shares	Value	Source
1	BDTX Black Diamond Therapeutics, Inc.	2 officers/directors Cluster buy RA CAPITAL MANAGEMENT, L.P., Ali Behbahani, Growth N. Biotech V	1,935,850	$9.7M +$5.0M by large holders	SEC filings
2	AENT ALLIANCE ENTERTAINMENT HOLDING CORP	4 officers/directors Cluster buy Walter Tommy Donaldson III, Thomas M. Finke, Bruce A. Ogilvie Jr., Jeffrey Clinton Walker	333,200	$1000K	SEC filings
3	MLTX MoonLake Immunotherapeutics	10% Owner Bihua Chen	800,000	$40.0M	SEC filings
4	KKR FS Income Trust	10% Owner KKR Alternative Assets LLC	459,348	$12.9M	SEC filings
5	NRGX PIMCO Energy & Tactical Credit Opportunities Fund	10% Owner Saba Capital Management, L.P.	128,249	$2.0M	SEC filings
6	PLCE Childrens Place, Inc.	President and CEO Jane T. Elfers	43,000	$1.0M	SEC filings
7	ECAT BlackRock ESG Capital Allocation Term Trust	10% Owner Saba Capital Management, L.P.	63,184	$988K	SEC filings
8	CDZI CADIZ INC	10% Owner Heerema International Group Services SA	200,000	$800K	SEC filings
9	DOMO DOMO, INC.	Director Daniel David Daniel III	26,400	$358K	SEC filings
10	BICX BioCorRx Inc.	Director Joseph J. Galligan	171,296	$300K	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.